Europe will lose out to countries like the U.S. and Japan on new medical research, trials and treatments unless draft rules reforming the European pharmaceutical landscape change, the CEO of Danish drugmaker Novo Nordisk warned on Thursday.
"You're not getting the health benefit and you're not getting the economic activity level from the industry, either. A lose, lose, lose," he said in an interview.
The pharma industry, lobbying hard against parts of the draft, counters that this will introduce uncertainty over whether investment costs will be recouped before generic competition enters, while putting up regulatory hurdles that even the biggest companies will struggle to clear. The Commission's current draft was leaked in Brussels last month and will likely change even before debate in the European parliament and among governments.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Spring break: International bookings up 30% with many setting sights on EuropeA new AAA survey revealed that international travel bookings jumped more than 30% compared to 2022, underscoring how families are 'making up for lost time.'
Read more »
Europe's first megalithic monuments date back 6000 years agoSix thousand years old settlement were home to the earliest megalithic monument builders in Europe.
Read more »
Europe pushing for the moon to have its own time zoneWith more lunar missions than ever on the horizon, the European Space Agency wants to give the moon its own time zone.
Read more »
Genetics study lays bare Ice Age drama for humans in EuropeEurope was no balmy paradise during the Ice Age, with the vast glaciers that blanketed large parts of the continent rendering wide swathes inhospitable for humans. But our species - a new immigrant to Europe - endured, though with great hardship.
Read more »
Ancient DNA unveils disparate fates of Ice Age hunter-gatherers in EuropeAncient DNA unveils two regional populations that lived in what is now Europe and made similar tools but met different fates.
Read more »